NeuroTherapia

NeuroTherapia is a Cleveland-based biotechnology company dedicated to developing the novel small molecule NTRX-07 for the treatment of neurodegenerative diseases. NTRX-07 is an orally available small molecule that targets receptors known to be upregulated in diseases including Alzheimer's disease (AD), ALS, MS, and chronic pain syndromes.